Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Outcomes Study of Acutely Decompensated Congestive Heart Failure Treated Initially in Outpatients With Natrecor (Nesiritide) - The PROACTION Trial

NCT00270387 is registered in ClinicalTrials.gov with Scios, Inc. as lead sponsor.

NCT NCT00270387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00270387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Outcomes Study of Acutely Decompensated Congestive Heart Failure Treated Initially in Outpatients With Natrecor (Nesiritide) - The PROACTION Trial
Lead sponsor
Scios, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2001
Completion date
January 31, 2002
Enrollment
250 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathies, dyspnea, paroxysma, heart failure, congestive